2007 - a special anniversary year for Dräger

Drägerwerk AG100 years ago in October 1907, company founder, Johann Heinrich Dräger, was awarded a patent for the Pulmotor, the first mobile short-term respirator. This marked the birth of ventilation technology development at Dräger. Simple, reliable, and extremely effective, the apparatus - transported in a wooden casket - quickly became a standard piece of equipment used by rescue services throughout Germany.

It all began early in the 20th century, when, on a trip to England, Johann Heinrich Dräger witnessed a young man being pulled out the Thames and resuscitated using the traditional Schaeffer method. Still in London, Dräger then produced some initial sketches. Upon returning to Lübeck, he began developing a technical solution for a resuscitation machine. After a few more modifications, the result was "Dräger's Pulmotor, the first automatic oxygen resuscitation machine for artificial respiration", manufactured in the factory and construction institute for oxygen apparatus known at the time as Drägerwerk in Lübeck, Germany. In his memoirs, Johann Heinrich Dräger spoke of the Pulmotor as having enabled well over 1,000 officially attested resuscitations by March 1, 1917.

Successful attempts at resuscitating miners poisoned by carbon monoxide, for example, paid testament to the success of the oxygen machine just a short time after its market launch in 1908 - in defiance of the skeptics of positive pressure respiration. Dräger consequently started serial production which, even at that time, proved extremely successful in the United States. The first Dräger company on US soil was founded in the US in 1907, too: at 11 Broadway in New York City; shortly afterwards, the company was moved to Pittsburgh, PA, and renamed Draeger Oxygen Apparatus Company. Internationality and innovativeness have a long tradition at Dräger.

In the US, the Pulmotor respirator was bought mainly to equip rescue teams of mining companies (mine rescuers) and fire departments, hence Dräger's legendary reputation for breathing apparatus in the US: mine rescuers equipped with Dräger apparatus were known as Draegermen.

The Oxylog product family, which is still going strong today, superseded the successful Pulmotor in 1978. After the first applications of the Iron Lung in the fifties, long-term positive pressure ventilation was introduced. Today, this is fulfilled by the intensive care ventilators of the Evita family. All of these devices are based on the technical specifications of the Pulmotor. In fact, advancements in this technical innovation from the beginning of the 20th century are now not only used for emergency and long-term ventilation, but also in anesthesia and for home care.

For further information, please visit:
http://www.draeger.com

Most Popular Now

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

NIH-Developed AI Algorithm Successfully …

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials...

Heart Attacks could be Ruled Out Early w…

As many as 60% of people presenting to emergency departments around the world with heart attack symptoms could be safely sent home, many at earlier stages, with the support of...

Northern Ireland's Laboratory Servi…

The transformation of pathology services across Northern Ireland has achieved another milestone, with the completion of phase three of the CoreLIMS programme to deploy Clinisys WinPath to all five health...

MEDICA 2024 and COMPAMED 2024: Medical T…

11 - 14 November 2024, Düsseldorf, Germany. "Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto...

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...